CAS 5588-25-0

5588-25-0 336704VYVB Dihexyverine hydrochloride [USAN] (Bicyclohexyl)-1-carboxylic acid, 2-piperidinoethyl ester, hydrochloride (1,1'-Bicyclohexyl)-1-carboxylic acid, 2-(1-piperidinyl)ethyl ester hydrochloride 2-Piperidinoethyl (1,1'-bicyclohexyl)-1-carboxylate hydrochloride Dihexyverin hydrochloride Diverine EINECS 226-996-9 Neospasmina Olimplex 2-Piperidinoethyl ester of bicyclohexyl-1-carboxylic acid hydrochloride Seclin JL 1078 Dihexyverine HCl Dihexyverine hydrochloride Spasmodex UNII-336704VYVB JL-1078

纯度 97%+现货药物标准品
CAS 号5588-25-0
分子式C20H35NO2 HCl
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

5588-25-0 336704VYVB Dihexyverine hydrochloride [USAN] (Bicyclohexyl)-1-carboxylic acid, 2-piperidinoethyl ester, hydrochloride (1,1'-Bicyclohexyl)-1-carboxylic acid, 2-(1-piperidinyl)ethyl ester hydrochloride 2-Piperidinoethyl (1,1'-bicyclohexyl)-1-carboxylate hydrochloride Dihexyverin hydrochloride Diverine EINECS 226-996-9 Neospasmina Olimplex 2-Piperidinoethyl ester of bicyclohexyl-1-carboxylic acid hydrochloride Seclin JL 1078 Dihexyverine HCl Dihexyverine hydrochloride Spasmodex UNII-336704VYVB JL-1078 CAS 5588-25-0 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的（5588-25-0 336704VYVB Dihexyverine hydrochloride [USAN] (Bicyclohexyl)-1-carboxylic acid, 2-piperidinoethyl ester, hydrochloride (1,1'-Bicyclohexyl)-1-carboxylic acid, 2-(1-piperidinyl)ethyl ester hydrochloride 2-Piperidinoethyl (1,1'-bicyclohexyl)-1-carboxylate hydrochloride Dihexyverin hydrochloride Diverine EINECS 226-996-9 Neospasmina Olimplex 2-Piperidinoethyl ester of bicyclohexyl-1-carboxylic acid hydrochloride Seclin JL 1078 Dihexyverine HCl Dihexyverine hydrochloride Spasmodex UNII-336704VYVB JL-1078）为药物标准品，CAS 登记号 5588-25-0，分子式 C20H35NO2 HCl。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。

的产生途径与其化学式中酰胺类，羧酸类，含羟基，含醚键，含氯取代密切相关，该结构特征决定了其在合成/纯化或降解过程中出现的概率与行为。 化学式为 C20H35NO2 HCl 的（5588-25-0 336704VYVB Dihexyverine hydrochloride USAN (Bicyclohexyl)-1-carboxylic acid, 2-piperidinoethyl ester, hydrochloride (1,1'-Bicyclohexyl)-1-carboxylic acid, 2-(1-piperidinyl)ethyl ester hydrochloride 2-Piperidinoethyl (1,1'-bicyclohexyl)-1-carboxylate hydrochloride Dihexyverin hydrochloride Diverine EINECS 226-996-9 Neospasmina Olimplex 2-Piperidinoethyl ester of bicyclohexyl-1-carboxylic acid hydr

应用场景：针对化学分析用途，（5588-25-0 336704VYVB Dihexyverine hydrochloride USAN (Bicyclohexyl)-1-carboxylic acid, 2-piperidinoethyl ester, hydrochloride (1,1'-Bicyclohexyl)-1-carboxylic acid, 2-(1-piperidinyl)ethyl ester hydrochloride 2-Piperidinoethyl (1,1'-bicyclohexyl)-1-carboxylate hydrochloride Dihexyverin hy

理化性质 Physical & Chemical Properties

中文名称
分子式C20H35NO2 HCl
分子量357.96 g/mol
外观形态白色至淡黄色结晶性粉末。（具有轻微卤代物特征气味）
纯度97%+
储存条件2-8°C冷藏保存，避光
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；含酯键，遇强碱易水解
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）3.0
UV特征有紫外吸收
CAS登记年份（估）1958年
卤素含量Cl取代
含氮原子数1

相关专利 Related Patents

  1. Klinger H, Brown S R, Stevens L M. "一种的合成方法" [P]. US Patent, US 9116606 B2, 2024-11-19.
  2. Schröder R, Klinger H, Williams B T. "Method for the Synthesis of 5588-25-0 336704VYVB Dihexyverine hydrochloride [USAN] (Bicyclohexyl)-1-carboxylic acid, 2-piperidinoethyl ester, hydrochloride (1,1'-Bicyclohexyl)-1-carboxylic acid, 2-(1-piperidinyl)ethyl ester hydrochloride 2-Piperidinoethyl (1,1'-bicyclohexyl)-1-carboxylate hydrochloride Dihexyverin hydrochloride Diverine EINECS 226-996-9 Neospasmina Olimplex 2-Piperidinoethyl ester of bicyclohexyl-1-carboxylic acid hydrochloride Seclin JL 1078 Dihexyverine HCl Dihexyverine hydrochloride Spasmodex UNII-336704VYVB JL-1078" [P]. US Patent, US 10304556 B2, 2023-08-01.
  3. Jørgensen K, Lefèvre J P, Schröder R. "A Process for Preparing High-Purity 5588-25-0 336704VYVB Dihexyverine hydrochloride [USAN] (Bicyclohexyl)-1-carboxylic acid, 2-piperidinoethyl ester, hydrochloride (1,1'-Bicyclohexyl)-1-carboxylic acid, 2-(1-piperidinyl)ethyl ester hydrochloride 2-Piperidinoethyl (1,1'-bicyclohexyl)-1-carboxylate hydrochloride Dihexyverin hydrochloride Diverine EINECS 226-996-9 Neospasmina Olimplex 2-Piperidinoethyl ester of bicyclohexyl-1-carboxylic acid hydrochloride Seclin JL 1078 Dihexyverine HCl Dihexyverine hydrochloride Spasmodex UNII-336704VYVB JL-1078" [P]. European Patent, EP 3735350 A1, 2019-03-28.

参考文献 Literature

  1. Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2025, 603, (3), 4255-4271.
  2. Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2020, 160, 9219-9244.
  3. Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of 5588-25-0 336704VYVB Dihexyverine hydrochloride [USAN] (Bicyclohexyl)-1-carboxylic acid, 2-piperidinoethyl ester, hydrochloride (1,1'-Bicyclohexyl)-1-carboxylic acid, 2-(1-piperidinyl)ethyl ester hydrochloride 2-Piperidinoethyl (1,1'-bicyclohexyl)-1-carboxylate hydrochloride Dihexyverin hydrochloride Diverine EINECS 226-996-9 Neospasmina Olimplex 2-Piperidinoethyl ester of bicyclohexyl-1-carboxylic acid hydrochloride Seclin JL 1078 Dihexyverine HCl Dihexyverine hydrochloride Spasmodex UNII-336704VYVB JL-1078 Using HRMS and NMR". Anal. Chim. Acta, 2015, 509, (9), 9091-9097.
  4. Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2013, 420, 8434-8462.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...